News & Events

Show:
May 25, 2022

Crinetics Reviews Phase 1 CRN04894 Multiple-Ascending Dose Data

Event Date: May 25, 2022

READ MORE
May 25, 2022

Crinetics Reports Top-line CRN04894 MAD Results from Phase 1 Study

Crinetics Reports Top-Line Phase 1 MAD results showing CRN04894 suppresses cortisol even in presence of disease-like ACTH concentrations

READ MORE
May 12, 2022

Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Crinetics reported financial results for the first quarter 2022 and outlined recent progress, including Phase 1 readout from CRN04777, licensing...

READ MORE
May 10, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces Inducement Grants The stock options were granted as inducements material to the employees entering into employment with...

READ MORE
April 18, 2022

Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering

Crinetics closed an underwritten public offering of 5,625,563 shares of its common stock, resulting in gross proceeds of approximately $125.0...

READ MORE
April 13, 2022

Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering

announced today the pricing of an underwritten follow-on offering of 5,625,563 shares of its common stock at a price to...

READ MORE
April 11, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
March 30, 2022

Crinetics Reviews Phase 1 CRN04777 Multiple-Ascending Dose Data

Event Date: March 30, 2022

READ MORE
March 30, 2022

Crinetics Reports Positive Top-Line Results from CRN04777 Phase 1 MAD Cohorts

Crinetics ($CRNX) reports results from CRN04777 Phase 1 MAD study that support potential to treat hyperinsulinism regardless of underlying genetic...

READ MORE
March 30, 2022

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

Crinetics reported financial results and provided a business update, noting that key milestones were achieved, significant additional capital raised, and...

READ MORE